David Wood received his undergraduate degree from Caltech in 1990 with a double major in Chemical Engineering and Molecular Biology.  He has biopharmaceutical industry experience working on Neupogen^® manufacturing at Amgen and downstream process development at Bristol Myers Squibb, and well as commodity scale bioprocess development at CP Kelco.  Since receiving his PhD from Rensselaer Polytechnic Institute in 2000, professor Wood has developed groundbreaking new technologies in downstream bioprocessing, with a focus on self-cleaving affinity tag methods.  His work has led to several issued patents in this area, and he is now an active consultant in the area of biosimilars development and intellectual property, as well as a co-founder of Protein Capture Science, a startup company commercializing his self-cleaving affinity tag technology.